UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
American Public Education
APEI
$940M
| $346K | ﹤0.01% |
11,680
+1,700
| +17% | +$47.6K |
|
2202
SIGA Technologies
SIGA
$219M
| $343K | ﹤0.01% |
57,961
+43,261
| +294% | +$247K |
|
|
CNR
2203
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $342K | ﹤0.01% |
56,476
-22,132
| -28% | -$113K |
|
2204
Liberty Energy
LBRT
$3.25B
| $341K | ﹤0.01% |
62,273
-4,000
| -6% | -$18.8K |
|
2205
EverQuote
EVER
$906M
| $337K | ﹤0.01% |
+5,800
| New | +$273K |
|
2206
Kelly Services Class A
KELYA
$527M
| $336K | ﹤0.01% |
21,237
-2,292
| -10% | -$32.8K |
|
|
TBIO
2207
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $335K | ﹤0.01% |
+18,700
| New | +$282K |
|
|
TMUSR
2208
DELISTED
T-Mobile US, Inc. Subscription Rights Expiring 7/27/2020
TMUSR
| $335K | ﹤0.01% |
+1,992,289
| New | +$559K |
|
2209
Varex Imaging
VREX
$523M
| $334K | ﹤0.01% |
22,041
-9,574
| -30% | -$193K |
|
2210
Anika Therapeutics
ANIK
$287M
| $333K | ﹤0.01% |
8,829
-6,955
| -44% | -$229K |
|
|
TELL
2211
DELISTED
Tellurian Inc.
TELL
| $330K | ﹤0.01% |
286,876
+153,117
| +114% | +$194K |
|
|
QTNT
2212
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $328K | ﹤0.01% |
1,108
+65
| +6% | +$18.7K |
|
2213
Par Pacific Holdings
PARR
$3.32B
| $328K | ﹤0.01% |
36,471
-1,567
| -4% | -$13.5K |
|
2214
MYR Group
MYRG
$5.25B
| $327K | ﹤0.01% |
+10,254
| New | +$280K |
|
2215
1-800-Flowers.com
FLWS
$258M
| $322K | ﹤0.01% |
16,079
-10,687
| -40% | -$211K |
|
|
BLU
2216
DELISTED
BELLUS Health Inc.
BLU
| $321K | ﹤0.01% |
+31,100
| New | +$315K |
|
2217
SunCoke Energy
SXC
$797M
| $321K | ﹤0.01% |
108,350
-20,293
| -16% | -$64.8K |
|
|
APTS
2218
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $319K | ﹤0.01% |
42,034
+1,226
| +3% | +$8.9K |
|
2219
Universal Insurance Holdings
UVE
$1.23B
| $316K | ﹤0.01% |
17,805
-17,636
| -50% | -$312K |
|
2220
ATN International
ATNI
$492M
| $315K | ﹤0.01% |
5,204
-314
| -6% | -$18.8K |
|
|
TBRG
2221
DELISTED
TruBridge
TBRG
| $315K | ﹤0.01% |
13,815
-10,320
| -43% | -$230K |
|
|
JCAP
2222
DELISTED
Jernigan Capital, Inc.
JCAP
| $314K | ﹤0.01% |
22,986
-8,612
| -27% | -$111K |
|
|
EGRX
2223
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $313K | ﹤0.01% |
6,529
+128
| +2% | +$6.39K |
|
2224
AngioDynamics
ANGO
$649M
| $311K | ﹤0.01% |
30,628
+2,992
| +11% | +$30.8K |
|
2225
WisdomTree
WT
$3.22B
| $310K | ﹤0.01% |
89,329
-17,472
| -16% | -$53.1K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.